世界の全ゲノム・エクソームシーケンス市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Whole Genome and Exome Sequencing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A11999 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、全ゲノム・エクソームシーケンスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。全ゲノム・エクソームシーケンスの種類別市場規模（キット、機器）、用途別市場規模（病院・クリニック、製薬・バイオテクノロジー企業、診断研究所、研究センター、学術・政府機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・全ゲノム・エクソームシーケンスの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eurofins Scientific SE、Agilent Technologies, Inc、Beijing Genomics Institute (BGI)、Hoffmann-La Roche Ltd、Bio-Rad Laboratories, Inc、GENEWIZ, Inc、Illumina, Inc、Laboratory Corporation of America Holdings、Novogene Corporation、Oxford Nanopore Technologies, Inc、Pacific Biosciences of California, Inc、QIAGEN N.V、Thermo Fisher Scientific Inc、Cytiva ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：キット、機器 ・用途別分析2016年-2026年：病院・クリニック、製薬・バイオテクノロジー企業、診断研究所、研究センター、学術・政府機関、その他 ・全ゲノム・エクソームシーケンスの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・全ゲノム・エクソームシーケンスのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・全ゲノム・エクソームシーケンスのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・全ゲノム・エクソームシーケンスの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・全ゲノム・エクソームシーケンスの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Whole Genome and Exome Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Whole Genome and Exome Sequencing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Whole Genome and Exome Sequencing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Whole Genome and Exome Sequencing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Kits
Instruments

Market segment by Application, can be divided into
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres, Academia and Government Institutes
Others

Market segment by players, this report covers
Eurofins Scientific SE
Agilent Technologies, Inc
Beijing Genomics Institute (BGI)
Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
GENEWIZ, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Novogene Corporation
Oxford Nanopore Technologies, Inc
Pacific Biosciences of California, Inc
QIAGEN N.V
Thermo Fisher Scientific Inc
Cytiva

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Whole Genome and Exome Sequencing
1.2 Classification of Whole Genome and Exome Sequencing by Type
1.2.1 Overview: Global Whole Genome and Exome Sequencing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Whole Genome and Exome Sequencing Revenue Market Share by Type in 2020
1.2.3 Kits
1.2.4 Instruments
1.3 Global Whole Genome and Exome Sequencing Market by Application
1.3.1 Overview: Global Whole Genome and Exome Sequencing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Diagnostic Labs
1.3.5 Research Centres, Academia and Government Institutes
1.3.6 Others
1.4 Global Whole Genome and Exome Sequencing Market Size & Forecast
1.5 Global Whole Genome and Exome Sequencing Market Size and Forecast by Region
1.5.1 Global Whole Genome and Exome Sequencing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Whole Genome and Exome Sequencing Market Size by Region, (2016-2021)
1.5.3 North America Whole Genome and Exome Sequencing Market Size and Prospect (2016-2026)
1.5.4 Europe Whole Genome and Exome Sequencing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Whole Genome and Exome Sequencing Market Size and Prospect (2016-2026)
1.5.6 South America Whole Genome and Exome Sequencing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Whole Genome and Exome Sequencing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Whole Genome and Exome Sequencing Market Drivers
1.6.2 Whole Genome and Exome Sequencing Market Restraints
1.6.3 Whole Genome and Exome Sequencing Trends Analysis
2 Company Profiles
2.1 Eurofins Scientific SE
2.1.1 Eurofins Scientific SE Details
2.1.2 Eurofins Scientific SE Major Business
2.1.3 Eurofins Scientific SE Whole Genome and Exome Sequencing Product and Solutions
2.1.4 Eurofins Scientific SE Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Eurofins Scientific SE Recent Developments and Future Plans
2.2 Agilent Technologies, Inc
2.2.1 Agilent Technologies, Inc Details
2.2.2 Agilent Technologies, Inc Major Business
2.2.3 Agilent Technologies, Inc Whole Genome and Exome Sequencing Product and Solutions
2.2.4 Agilent Technologies, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Agilent Technologies, Inc Recent Developments and Future Plans
2.3 Beijing Genomics Institute (BGI)
2.3.1 Beijing Genomics Institute (BGI) Details
2.3.2 Beijing Genomics Institute (BGI) Major Business
2.3.3 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product and Solutions
2.3.4 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Beijing Genomics Institute (BGI) Recent Developments and Future Plans
2.4 Hoffmann-La Roche Ltd
2.4.1 Hoffmann-La Roche Ltd Details
2.4.2 Hoffmann-La Roche Ltd Major Business
2.4.3 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product and Solutions
2.4.4 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.5 Bio-Rad Laboratories, Inc
2.5.1 Bio-Rad Laboratories, Inc Details
2.5.2 Bio-Rad Laboratories, Inc Major Business
2.5.3 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product and Solutions
2.5.4 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bio-Rad Laboratories, Inc Recent Developments and Future Plans
2.6 GENEWIZ, Inc
2.6.1 GENEWIZ, Inc Details
2.6.2 GENEWIZ, Inc Major Business
2.6.3 GENEWIZ, Inc Whole Genome and Exome Sequencing Product and Solutions
2.6.4 GENEWIZ, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GENEWIZ, Inc Recent Developments and Future Plans
2.7 Illumina, Inc
2.7.1 Illumina, Inc Details
2.7.2 Illumina, Inc Major Business
2.7.3 Illumina, Inc Whole Genome and Exome Sequencing Product and Solutions
2.7.4 Illumina, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Illumina, Inc Recent Developments and Future Plans
2.8 Laboratory Corporation of America Holdings
2.8.1 Laboratory Corporation of America Holdings Details
2.8.2 Laboratory Corporation of America Holdings Major Business
2.8.3 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product and Solutions
2.8.4 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.9 Novogene Corporation
2.9.1 Novogene Corporation Details
2.9.2 Novogene Corporation Major Business
2.9.3 Novogene Corporation Whole Genome and Exome Sequencing Product and Solutions
2.9.4 Novogene Corporation Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Novogene Corporation Recent Developments and Future Plans
2.10 Oxford Nanopore Technologies, Inc
2.10.1 Oxford Nanopore Technologies, Inc Details
2.10.2 Oxford Nanopore Technologies, Inc Major Business
2.10.3 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product and Solutions
2.10.4 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Oxford Nanopore Technologies, Inc Recent Developments and Future Plans
2.11 Pacific Biosciences of California, Inc
2.11.1 Pacific Biosciences of California, Inc Details
2.11.2 Pacific Biosciences of California, Inc Major Business
2.11.3 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product and Solutions
2.11.4 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Pacific Biosciences of California, Inc Recent Developments and Future Plans
2.12 QIAGEN N.V
2.12.1 QIAGEN N.V Details
2.12.2 QIAGEN N.V Major Business
2.12.3 QIAGEN N.V Whole Genome and Exome Sequencing Product and Solutions
2.12.4 QIAGEN N.V Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 QIAGEN N.V Recent Developments and Future Plans
2.13 Thermo Fisher Scientific Inc
2.13.1 Thermo Fisher Scientific Inc Details
2.13.2 Thermo Fisher Scientific Inc Major Business
2.13.3 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product and Solutions
2.13.4 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
2.14 Cytiva
2.14.1 Cytiva Details
2.14.2 Cytiva Major Business
2.14.3 Cytiva Whole Genome and Exome Sequencing Product and Solutions
2.14.4 Cytiva Whole Genome and Exome Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Cytiva Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Whole Genome and Exome Sequencing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Whole Genome and Exome Sequencing Players Market Share
3.2.2 Top 10 Whole Genome and Exome Sequencing Players Market Share
3.2.3 Market Competition Trend
3.3 Whole Genome and Exome Sequencing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Whole Genome and Exome Sequencing Revenue and Market Share by Type (2016-2021)
4.2 Global Whole Genome and Exome Sequencing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2016-2021)
5.2 Whole Genome and Exome Sequencing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Whole Genome and Exome Sequencing Revenue by Type (2016-2026)
6.2 North America Whole Genome and Exome Sequencing Revenue by Application (2016-2026)
6.3 North America Whole Genome and Exome Sequencing Market Size by Country
6.3.1 North America Whole Genome and Exome Sequencing Revenue by Country (2016-2026)
6.3.2 United States Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
6.3.3 Canada Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
6.3.4 Mexico Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Whole Genome and Exome Sequencing Revenue by Type (2016-2026)
7.2 Europe Whole Genome and Exome Sequencing Revenue by Application (2016-2026)
7.3 Europe Whole Genome and Exome Sequencing Market Size by Country
7.3.1 Europe Whole Genome and Exome Sequencing Revenue by Country (2016-2026)
7.3.2 Germany Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
7.3.3 France Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
7.3.5 Russia Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
7.3.6 Italy Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Whole Genome and Exome Sequencing Revenue by Type (2016-2026)
8.2 Asia-Pacific Whole Genome and Exome Sequencing Revenue by Application (2016-2026)
8.3 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region
8.3.1 Asia-Pacific Whole Genome and Exome Sequencing Revenue by Region (2016-2026)
8.3.2 China Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
8.3.3 Japan Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
8.3.4 South Korea Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
8.3.5 India Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
8.3.7 Australia Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Whole Genome and Exome Sequencing Revenue by Type (2016-2026)
9.2 South America Whole Genome and Exome Sequencing Revenue by Application (2016-2026)
9.3 South America Whole Genome and Exome Sequencing Market Size by Country
9.3.1 South America Whole Genome and Exome Sequencing Revenue by Country (2016-2026)
9.3.2 Brazil Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
9.3.3 Argentina Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Whole Genome and Exome Sequencing Revenue by Type (2016-2026)
10.2 Middle East & Africa Whole Genome and Exome Sequencing Revenue by Application (2016-2026)
10.3 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country
10.3.1 Middle East & Africa Whole Genome and Exome Sequencing Revenue by Country (2016-2026)
10.3.2 Turkey Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
10.3.4 UAE Whole Genome and Exome Sequencing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Whole Genome and Exome Sequencing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Whole Genome and Exome Sequencing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Whole Genome and Exome Sequencing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Whole Genome and Exome Sequencing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Whole Genome and Exome Sequencing Revenue Market Share by Region (2021-2026)
Table 6. Eurofins Scientific SE Corporate Information, Head Office, and Major Competitors
Table 7. Eurofins Scientific SE Major Business
Table 8. Eurofins Scientific SE Whole Genome and Exome Sequencing Product and Solutions
Table 9. Eurofins Scientific SE Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Agilent Technologies, Inc Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies, Inc Major Business
Table 12. Agilent Technologies, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 13. Agilent Technologies, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Beijing Genomics Institute (BGI) Corporate Information, Head Office, and Major Competitors
Table 15. Beijing Genomics Institute (BGI) Major Business
Table 16. Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product and Solutions
Table 17. Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 19. Hoffmann-La Roche Ltd Major Business
Table 20. Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product and Solutions
Table 21. Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bio-Rad Laboratories, Inc Corporate Information, Head Office, and Major Competitors
Table 23. Bio-Rad Laboratories, Inc Major Business
Table 24. Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 25. Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GENEWIZ, Inc Corporate Information, Head Office, and Major Competitors
Table 27. GENEWIZ, Inc Major Business
Table 28. GENEWIZ, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 29. GENEWIZ, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Illumina, Inc Corporate Information, Head Office, and Major Competitors
Table 31. Illumina, Inc Major Business
Table 32. Illumina, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 33. Illumina, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Laboratory Corporation of America Holdings Corporate Information, Head Office, and Major Competitors
Table 35. Laboratory Corporation of America Holdings Major Business
Table 36. Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product and Solutions
Table 37. Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Novogene Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Novogene Corporation Major Business
Table 40. Novogene Corporation Whole Genome and Exome Sequencing Product and Solutions
Table 41. Novogene Corporation Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Oxford Nanopore Technologies, Inc Corporate Information, Head Office, and Major Competitors
Table 43. Oxford Nanopore Technologies, Inc Major Business
Table 44. Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 45. Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Pacific Biosciences of California, Inc Corporate Information, Head Office, and Major Competitors
Table 47. Pacific Biosciences of California, Inc Major Business
Table 48. Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product and Solutions
Table 49. Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. QIAGEN N.V Corporate Information, Head Office, and Major Competitors
Table 51. QIAGEN N.V Major Business
Table 52. QIAGEN N.V Whole Genome and Exome Sequencing Product and Solutions
Table 53. QIAGEN N.V Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Thermo Fisher Scientific Inc Corporate Information, Head Office, and Major Competitors
Table 55. Thermo Fisher Scientific Inc Major Business
Table 56. Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product and Solutions
Table 57. Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Cytiva Corporate Information, Head Office, and Major Competitors
Table 59. Cytiva Major Business
Table 60. Cytiva Whole Genome and Exome Sequencing Product and Solutions
Table 61. Cytiva Whole Genome and Exome Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Whole Genome and Exome Sequencing Revenue (USD Million) by Players (2019-2021)
Table 63. Global Whole Genome and Exome Sequencing Revenue Share by Players (2019-2021)
Table 64. Breakdown of Whole Genome and Exome Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Whole Genome and Exome Sequencing Players Head Office, Products and Services Provided
Table 66. Whole Genome and Exome Sequencing Mergers & Acquisitions in the Past Five Years
Table 67. Whole Genome and Exome Sequencing New Entrants and Expansion Plans
Table 68. Global Whole Genome and Exome Sequencing Revenue (USD Million) by Type (2016-2021)
Table 69. Global Whole Genome and Exome Sequencing Revenue Share by Type (2016-2021)
Table 70. Global Whole Genome and Exome Sequencing Revenue Forecast by Type (2021-2026)
Table 71. Global Whole Genome and Exome Sequencing Revenue by Application (2016-2021)
Table 72. Global Whole Genome and Exome Sequencing Revenue Forecast by Application (2021-2026)
Table 73. North America Whole Genome and Exome Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Whole Genome and Exome Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Whole Genome and Exome Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Whole Genome and Exome Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Whole Genome and Exome Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Whole Genome and Exome Sequencing Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Whole Genome and Exome Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Whole Genome and Exome Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Whole Genome and Exome Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Whole Genome and Exome Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Whole Genome and Exome Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Whole Genome and Exome Sequencing Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Whole Genome and Exome Sequencing Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Whole Genome and Exome Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Whole Genome and Exome Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Whole Genome and Exome Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Whole Genome and Exome Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Whole Genome and Exome Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Whole Genome and Exome Sequencing Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Whole Genome and Exome Sequencing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Whole Genome and Exome Sequencing Picture
Figure 2. Global Whole Genome and Exome Sequencing Revenue Market Share by Type in 2020
Figure 3. Kits
Figure 4. Instruments
Figure 5. Whole Genome and Exome Sequencing Revenue Market Share by Application in 2020
Figure 6. Hospitals and Clinics Picture
Figure 7. Pharmaceutical and Biotechnology Companies Picture
Figure 8. Diagnostic Labs Picture
Figure 9. Research Centres, Academia and Government Institutes Picture
Figure 10. Others Picture
Figure 11. Global Whole Genome and Exome Sequencing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Whole Genome and Exome Sequencing Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Whole Genome and Exome Sequencing Revenue Market Share by Region (2016-2026)
Figure 14. Global Whole Genome and Exome Sequencing Revenue Market Share by Region in 2020
Figure 15. North America Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Whole Genome and Exome Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Whole Genome and Exome Sequencing Market Drivers
Figure 21. Whole Genome and Exome Sequencing Market Restraints
Figure 22. Whole Genome and Exome Sequencing Market Trends
Figure 23. Eurofins Scientific SE Recent Developments and Future Plans
Figure 24. Agilent Technologies, Inc Recent Developments and Future Plans
Figure 25. Beijing Genomics Institute (BGI) Recent Developments and Future Plans
Figure 26. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 27. Bio-Rad Laboratories, Inc Recent Developments and Future Plans
Figure 28. GENEWIZ, Inc Recent Developments and Future Plans
Figure 29. Illumina, Inc Recent Developments and Future Plans
Figure 30. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Figure 31. Novogene Corporation Recent Developments and Future Plans
Figure 32. Oxford Nanopore Technologies, Inc Recent Developments and Future Plans
Figure 33. Pacific Biosciences of California, Inc Recent Developments and Future Plans
Figure 34. QIAGEN N.V Recent Developments and Future Plans
Figure 35. Thermo Fisher Scientific Inc Recent Developments and Future Plans
Figure 36. Cytiva Recent Developments and Future Plans
Figure 37. Global Whole Genome and Exome Sequencing Revenue Share by Players in 2020
Figure 38. Whole Genome and Exome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Whole Genome and Exome Sequencing Revenue Market Share in 2020
Figure 40. Global Top 10 Players Whole Genome and Exome Sequencing Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Whole Genome and Exome Sequencing Revenue Share by Type in 2020
Figure 43. Global Whole Genome and Exome Sequencing Market Share Forecast by Type (2021-2026)
Figure 44. Global Whole Genome and Exome Sequencing Revenue Share by Application in 2020
Figure 45. Global Whole Genome and Exome Sequencing Market Share Forecast by Application (2021-2026)
Figure 46. North America Whole Genome and Exome Sequencing Sales Market Share by Type (2016-2026)
Figure 47. North America Whole Genome and Exome Sequencing Sales Market Share by Application (2016-2026)
Figure 48. North America Whole Genome and Exome Sequencing Revenue Market Share by Country (2016-2026)
Figure 49. United States Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Whole Genome and Exome Sequencing Sales Market Share by Type (2016-2026)
Figure 53. Europe Whole Genome and Exome Sequencing Sales Market Share by Application (2016-2026)
Figure 54. Europe Whole Genome and Exome Sequencing Revenue Market Share by Country (2016-2026)
Figure 55. Germany Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Whole Genome and Exome Sequencing Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Whole Genome and Exome Sequencing Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Whole Genome and Exome Sequencing Revenue Market Share by Region (2016-2026)
Figure 63. China Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Whole Genome and Exome Sequencing Sales Market Share by Type (2016-2026)
Figure 70. South America Whole Genome and Exome Sequencing Sales Market Share by Application (2016-2026)
Figure 71. South America Whole Genome and Exome Sequencing Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Whole Genome and Exome Sequencing Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Whole Genome and Exome Sequencing Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Whole Genome and Exome Sequencing Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Whole Genome and Exome Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source

---